These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24751999)

  • 1. Clinical use of fertility agents and risk of breast cancer: a recent update for an old problem.
    Tomao F; Lo Russo G; Spinelli GP; Tomao S
    Curr Opin Obstet Gynecol; 2014 Jun; 26(3):130-7. PubMed ID: 24751999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk after exposure to fertility drugs.
    Lo Russo G; Spinelli GP; Tomao S; Rossi B; Frati L; Panici PB; Vici P; Codacci Pisanelli G; Tomao F
    Expert Rev Anticancer Ther; 2013 Feb; 13(2):149-57. PubMed ID: 23406556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
    Gadducci A; Guerrieri ME; Genazzani AR
    Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infertility, fertility treatment and breast cancer risk].
    Riskin-Mashiah S
    Harefuah; 2013 Oct; 152(10):600-4, 623. PubMed ID: 24450034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
    Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
    Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fertilization and breast cancer risk: a review.
    Salhab M; Al Sarakbi W; Mokbel K
    Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomiphene ovulation induction and higher-order multiple pregnancy.
    McDowell S; Kroon B; Yazdani A
    Aust N Z J Obstet Gynaecol; 2013 Aug; 53(4):395-8. PubMed ID: 23829327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
    Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
    Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infertility and ovarian cancer.
    Chatterjee SK
    J Indian Med Assoc; 1999 Feb; 97(2):69. PubMed ID: 10549200
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors.
    Del Pup L; Peccatori FA; Levi-Setti PE; Codacci-Pisanelli G; Patrizio P
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):8042-8059. PubMed ID: 30536354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infertility treatment and the risk of cancer.
    Storeng R; Vangen S; Omland AK; Oldereid NB
    Tidsskr Nor Laegeforen; 2012 Nov; 132(22):2494-9. PubMed ID: 23338030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.
    Ayhan A; Salman MC; Celik H; Dursun P; Ozyuncu O; Gultekin M
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1104-11. PubMed ID: 15548140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
    Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
    Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study.
    Tredway D; Schertz JC; Bock D; Hemsey G; Diamond MP
    Fertil Steril; 2011 Apr; 95(5):1725-9.e1-8. PubMed ID: 21316048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
    Venn A; Watson L; Bruinsma F; Giles G; Healy D
    Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
    Tredway D; Schertz JC; Bock D; Hemsey G; Diamond MP
    Fertil Steril; 2011 Apr; 95(5):1720-4.e1-8. PubMed ID: 21300344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer associated with ovulation induction: a case report.
    Adewole IF; Babarinsa IA; Thomas JO; Ajayi AB
    Afr J Med Med Sci; 1997; 26(3-4):203-4. PubMed ID: 10456173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcomes of infertile women by clomiphene citrate and letrozole with gonadotropins underwent intrauterine insemination.
    Zadehmodares S; Niyakan M; Sharafy SA; Yazdi MH; Jahed F
    Acta Med Iran; 2012; 50(1):18-20. PubMed ID: 22267373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.